BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

161 related articles for article (PubMed ID: 141763)

  • 21. Developments in the treatment of parkinsonism.
    Calne DB
    N Engl J Med; 1976 Dec; 295(25):1433-4. PubMed ID: 989886
    [No Abstract]   [Full Text] [Related]  

  • 22. Behavioral manifestations of movement disorders. Parkinson's and Huntington's disease.
    Mayeux R
    Neurol Clin; 1984 Aug; 2(3):527-40. PubMed ID: 6085395
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Brain dopamine receptor stimulation and the relief of Parkinsonism: relationship between bromocriptine and levodopa.
    Rinne UK; Marttila R
    Ann Neurol; 1978 Sep; 4(3):263-7. PubMed ID: 718139
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Interaction between bromocriptine and levodopa. Biochemical basis for an improved treatment for parkinsonism.
    Hutt CS; Snider SR; Fahn S
    Neurology; 1977 Jun; 27(6):503-10. PubMed ID: 577299
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Letter: Bromocriptine in parkinsonism.
    Debono AG; Donaldson I; Marsden CD; Parkes JD
    Lancet; 1975 Nov; 2(7942):987-8. PubMed ID: 53479
    [No Abstract]   [Full Text] [Related]  

  • 26. [Huntington's chorea and somatotropic hormone: dynamic explorations in 27 cases (author's transl)].
    Destée A; Petit H; Fossati P; Warot P
    Rev Neurol (Paris); 1981; 137(1):21-31. PubMed ID: 6453416
    [No Abstract]   [Full Text] [Related]  

  • 27. Brain dopamine turnover and the relief of parkinsonism.
    Rinne UK; Marttila R; Sonninen V
    Arch Neurol; 1977 Oct; 34(10):626-9. PubMed ID: 907536
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Biochemical investigations in Parkinsonism. A study of the metabolites of the biogenic amines in the lumbar CSF.
    Pullar IA; Dowson JH; Ahmed R; Chow R; Gillingham FJ
    Confin Neurol; 1972; 34(2):143-8. PubMed ID: 4666057
    [No Abstract]   [Full Text] [Related]  

  • 29. Amine precursors in neurologic disorders and the psychoses.
    Klawans H
    Res Publ Assoc Res Nerv Ment Dis; 1975; 54():259-76. PubMed ID: 130667
    [No Abstract]   [Full Text] [Related]  

  • 30. Neuroendocrinologic findings in patients with untreated Huntington's chorea.
    Caraceni TA; Parati EA; Giovannini PM; Grassi MP; Scigliano G; Carella F; Müller EE
    Arch Neurol; 1984 May; 41(5):516-20. PubMed ID: 6232913
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Neuroendocrine aspects of Parkinson's disease. Therapeutic/effect of a prolactin inhibitor].
    Agnoli A; Casacchia M; Carolei A; Meco G; Zamponi A; Ruggieri S
    Minerva Med; 1976 Nov; 67(53):. PubMed ID: 1036612
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Growth hormone and prolactin response to bromocriptine in patients with Huntington's chorea.
    Chalmers RJ; Johnson RH; Keogh HJ; Nanda RN
    J Neurol Neurosurg Psychiatry; 1978 Feb; 41(2):135-9. PubMed ID: 24678
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Recent developments in Parkinson's disease and Huntington's chorea.
    Barbeau A
    Int J Neurol; 1976; 11(1):17-27. PubMed ID: 138661
    [No Abstract]   [Full Text] [Related]  

  • 34. Treatment with disulfiram in huntington's chorea.
    Mattsson B; Bertilsson L
    Acta Psychiatr Scand Suppl; 1974; 255():261-8. PubMed ID: 4282557
    [No Abstract]   [Full Text] [Related]  

  • 35. Cerebrospinal fluid homovanillic acid and parkinsonism in Huntington's disease.
    Kurlan R; Goldblatt D; Zaczek R; Jeffries K; Irvine C; Coyle J; Shoulson I
    Ann Neurol; 1988 Aug; 24(2):282-4. PubMed ID: 2972251
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Lioresal in Huntington's disease.
    Paulson GW
    Dis Nerv Syst; 1976 Aug; 37(8):465-7. PubMed ID: 133792
    [No Abstract]   [Full Text] [Related]  

  • 37. [Effect of fenfluramine in Huntington Chorea].
    Roccatagliata G; Pizio N; Farinini D; Firpo MP; Bartolini A; Bacigalupo F; Albano C
    Rev Neurol (Paris); 1983; 139(10):589-92. PubMed ID: 6196830
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Bromocriptine and Parkinson's disease: initial results].
    Petit H; Destee A
    Lille Med; 1977; 22(6):362-5. PubMed ID: 578286
    [No Abstract]   [Full Text] [Related]  

  • 39. Role of ergot derivatives in the treatment of parkinsonism.
    Calne DB
    Fed Proc; 1978 Jun; 37(8):2207-9. PubMed ID: 658459
    [No Abstract]   [Full Text] [Related]  

  • 40. Comparison between lergotrile and bromocriptine in parkinsonism.
    Teychenne PF; Pfeiffer RF; Bern SM; McInturff D; Calne DB
    Ann Neurol; 1978 Apr; 3(4):319-24. PubMed ID: 666273
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.